151 related articles for article (PubMed ID: 19822802)
1. Inhibition of the adenosine2A receptor-epoxyeicosatrienoic acid pathway renders Dahl salt-resistant rats hypertensive.
Liclican EL; Doumad AB; Wang J; Li J; Falck JR; Stier CT; Carroll MA
Hypertension; 2009 Dec; 54(6):1284-90. PubMed ID: 19822802
[TBL] [Abstract][Full Text] [Related]
2. Role of the adenosine(2A) receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertension.
Carroll MA
Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):39-47. PubMed ID: 22227265
[TBL] [Abstract][Full Text] [Related]
3. Failure to upregulate the adenosine2A receptor-epoxyeicosatrienoic acid pathway contributes to the development of hypertension in Dahl salt-sensitive rats.
Liclican EL; McGiff JC; Falck JR; Carroll MA
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1696-704. PubMed ID: 18829737
[TBL] [Abstract][Full Text] [Related]
4. Modulation of V1-receptor-mediated renal vasoconstriction by epoxyeicosatrienoic acids.
Rajapakse NW; Roman RJ; Falck JR; Oliver JJ; Evans RG
Am J Physiol Regul Integr Comp Physiol; 2004 Jul; 287(1):R181-7. PubMed ID: 14988086
[TBL] [Abstract][Full Text] [Related]
5. Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat.
Hye Khan MA; Neckár J; Manthati V; Errabelli R; Pavlov TS; Staruschenko A; Falck JR; Imig JD
Hypertension; 2013 Nov; 62(5):905-13. PubMed ID: 23980070
[TBL] [Abstract][Full Text] [Related]
6. Sexual dimorphism of renal alpha2-adrenergic receptor regulation in Dahl rats.
Gong G; Dobin A; Johnson ML; Pettinger WA
Hypertens Res; 1996 Jun; 19(2):83-9. PubMed ID: 10968200
[TBL] [Abstract][Full Text] [Related]
7. Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids.
Liclican EL; McGiff JC; Pedraza PL; Ferreri NR; Falck JR; Carroll MA
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F386-92. PubMed ID: 15814528
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological manipulation of arachidonic acid-epoxygenase results in divergent effects on renal damage.
Li J; Stier CT; Chander PN; Manthati VL; Falck JR; Carroll MA
Front Pharmacol; 2014; 5():187. PubMed ID: 25177296
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure reduction by Japanese traditional Miso is associated with increased diuresis and natriuresis through dopamine system in Dahl salt-sensitive rats.
Du DD; Yoshinaga M; Sonoda M; Kawakubo K; Uehara Y
Clin Exp Hypertens; 2014; 36(5):359-66. PubMed ID: 24047246
[TBL] [Abstract][Full Text] [Related]
11. Two Pools of Epoxyeicosatrienoic Acids in Humans: Alterations in Salt-Sensitive Normotensive Subjects.
Elijovich F; Milne GL; Brown NJ; Laniado-Schwartzman M; Laffer CL
Hypertension; 2018 Feb; 71(2):346-355. PubMed ID: 29279315
[TBL] [Abstract][Full Text] [Related]
12. Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors.
Cheng MK; Doumad AB; Jiang H; Falck JR; McGiff JC; Carroll MA
Br J Pharmacol; 2004 Feb; 141(3):441-8. PubMed ID: 14718251
[TBL] [Abstract][Full Text] [Related]
13. Renal epoxyeicosatrienoic acid synthesis during pregnancy.
Zhou Y; Chang HH; Du J; Wang CY; Dong Z; Wang MH
Am J Physiol Renal Physiol; 2005 Jan; 288(1):F221-6. PubMed ID: 15383399
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis.
Dos Santos EA; Dahly-Vernon AJ; Hoagland KM; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2004 Jul; 287(1):R58-68. PubMed ID: 15031141
[TBL] [Abstract][Full Text] [Related]
15. L-arginine administration normalizes pressure natriuresis in hypertensive Dahl rats.
Patel A; Layne S; Watts D; Kirchner KA
Hypertension; 1993 Dec; 22(6):863-9. PubMed ID: 8244518
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats.
Yu M; Moreno C; Hoagland KM; Dahly A; Ditter K; Mistry M; Roman RJ
J Hypertens; 2003 Jun; 21(6):1125-35. PubMed ID: 12777949
[TBL] [Abstract][Full Text] [Related]
17. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
18. Adenosine2A receptors and epoxyeicosatrienoic acids: a recipe for salt and blood pressure regulation.
Imig JD
Hypertension; 2009 Dec; 54(6):1223-5. PubMed ID: 19822801
[No Abstract] [Full Text] [Related]
19. Inhibition of epoxyeicosatrienoic acid production in rats with cirrhosis has beneficial effects on portal hypertension by reducing splanchnic vasodilation.
Di Pascoli M; Zampieri F; Verardo A; Pesce P; Turato C; Angeli P; Sacerdoti D; Bolognesi M
Hepatology; 2016 Sep; 64(3):923-30. PubMed ID: 27312119
[TBL] [Abstract][Full Text] [Related]
20. Suppression of cortical functional hyperemia to vibrissal stimulation in the rat by epoxygenase inhibitors.
Peng X; Carhuapoma JR; Bhardwaj A; Alkayed NJ; Falck JR; Harder DR; Traystman RJ; Koehler RC
Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H2029-37. PubMed ID: 12384482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
